CONSOLIDATION IMMUNOTHERAPY

Clinical trials for CONSOLIDATION IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new CONSOLIDATION IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for CONSOLIDATION IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for lung cancer patients: drug combo targets remaining cancer cells after chemoradiation

Disease control Recruiting now

This study tests whether adding the drug QL1706 (which boosts the immune system) to chemotherapy before standard chemoradiation, followed by more immunotherapy, can help people with limited-stage small cell lung cancer live longer without the cancer growing. About 28 adults aged …

Matched conditions: CONSOLIDATION IMMUNOTHERAPY

Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control

Last updated Jun 18, 2026 11:51 UTC

CONSOLIDATION IMMUNOTHERAPY

Get alerted when new CONSOLIDATION IMMUNOTHERAPY trials appear

New hope for lung cancer patients: drug combo targets remaining cancer cells after chemoradiation